title: Aspirin resistance in cerebrovascular patients.
authors.forename: Andrea
authors.initials: A
authors.lastname: Feher
authors.forename: Gabriella
authors.initials: G
authors.lastname: Pusch
authors.forename: Gabor
authors.initials: G
authors.lastname: Harang
authors.forename: Beata
authors.initials: B
authors.lastname: Gasztonyi
authors.forename: Elod
authors.initials: E
authors.lastname: Papp
authors.forename: Dora
authors.initials: D
authors.lastname: Werling
authors.forename: Marianna
authors.initials: M
authors.lastname: Menyhart
authors.forename: Hedvig
authors.initials: H
authors.lastname: Komaromy
authors.forename: Laszlo
authors.initials: L
authors.lastname: Szapary
authors.forename: Gergely
authors.initials: G
authors.lastname: Feher
mesh_terms: D000368:Aged; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D002545:Brain Ischemia / Q000188:drug therapy* / Q000453:epidemiology; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin